Trial Profile
Cognitive Protection - Dexmedetomidine and Cognitive Reserve.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Cognition disorders; Delirium
- Focus Therapeutic Use
- 10 Jan 2012 New trial record